EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

Update of the EuroGuiDerm evidence‐based guideline for the treatment of acne—Short version

Alexander Nast iD, Bassel H Al Wattar, Marie Beylot Barry iD, Holger Brüggemann iD, Zrinka Bukvić Mokos, Dawn M Caruana, Klaus Degitz, Clio Dessinioti iD, Brigitte Dréno iD, Rieke J B Driessen, Harald Gollnick iD, Merete Hædersdal und 11 weitere

Journal of the European Academy of Dermatology and Venereology · 2026

DOI: 10.1111/jdv.70331 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2026. Verfasst von Alexander Nast und 22 weiteren Autor:innen. Beteiligte Einrichtung: Division of Evidence-Based Medicine, Klinik für Dermatologie, Charité - Universitätsmedizin Berlin, Berlin, Germany. Hauptthemen laut MEDLINE: Acne Vulgaris, Anti-Bacterial Agents, Dermatologic Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This evidence‐ and consensus‐based guideline for the treatment of acne was developed in accordance with the EuroGuiDerm Guideline and Consensus Statement Development Manual. This guideline is an update of the 2016 version. This is a short summary of the full version of the EuroGuiDerm Evidence‐based Guideline for the Treatment of Acne. For the complete guideline text, detailed methods report, and comprehensive evidence report, please refer to the online full version. In this targeted update, the guideline group prioritized three key clinical questions considered most relevant for current practice: (a) For which types of acne and patient groups should isotretinoin be recommended versus systemic antibiotics, and with what strength of recommendation? (b) What is the appropriate duration for systemic antibiotic therapy? For which types of acne and patient groups should hormonal treatments and spironolactone be recommended, and with what strength of recommendation? For which types of acne and patient groups should new topical treatments, including trifarotene and clascoterone, be recommended and with what strength of recommendation? Additionally, the updated guideline provides revised recommendations regarding: safety of benzoyl peroxide (BPO), selection of systemic antibiotic therapy, treatment considerations during pregnancy, isotretinoin dosing strategies, and the use of hormonal antiandrogenic contraceptives or other combined hormonal contraceptives, as well as spironolactone. All other aspects remain unchanged from the 2016 guideline.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acne VulgarisAnti-Bacterial AgentsDermatologic AgentsHumansEvidence-Based MedicineFemaleIsotretinoinBenzoyl PeroxidePregnancySpironolactone

Stichwörter der Autor:innen

acne vulgarisevidence‐based medicinemethodsoral administrationpractice guidelinetopical administration

Substanzen

Anti-Bacterial AgentsDermatologic AgentsIsotretinoinBenzoyl PeroxideSpironolactone

Autor:innen und Institutionen

  • Division of Evidence-Based Medicine, Klinik für Dermatologie, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Comprehensive Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK.
  • Beginnings Assisted Conception Unit, Epsom and St Helier University Hospitals, London, UK.
  • Dermatology Department, CHU Bordeaux, Bordeaux, France.
  • Université de Bordeaux, Bordeaux, France.
  • Department of Biomedicine, Aarhus University, Aarhus, Denmark.

ORCID-Profile: Alexander Nast, Marie Beylot Barry, Holger Brüggemann, Clio Dessinioti, Brigitte Dréno, Harald Gollnick, Alexander Katoulis, Giuseppe Micali

Zitieren

APA

Nast, A., Al Wattar, B. H., Beylot Barry, M., Brüggemann, H., Bukvić Mokos, Z., Caruana, D. M., Degitz, K., Dessinioti, C., Dréno, B., Driessen, R. J. B., Gollnick, H., Hædersdal, M., Katoulis, A., Läuchli, S., Lambert, J., Layton, A. M., Micali, G., Ochsendorf, F. R., Sathyapalan, T., …, & Pennitz, A. (2026). Update of the EuroGuiDerm evidence‐based guideline for the treatment of acne—Short version. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.70331

Vancouver

Nast A, Al Wattar BH, Beylot Barry M, Brüggemann H, Bukvić Mokos Z, Caruana DM, et al. Update of the EuroGuiDerm evidence‐based guideline for the treatment of acne—Short version. Journal of the European Academy of Dermatology and Venereology. 2026. doi:10.1111/jdv.70331

BibTeX
@article{Nast2026,
  author = {Nast, Alexander and Al Wattar, Bassel H and Beylot Barry, Marie and Brüggemann, Holger and Bukvić Mokos, Zrinka and Caruana, Dawn M and Degitz, Klaus and Dessinioti, Clio and Dréno, Brigitte and Driessen, Rieke J B and Gollnick, Harald and Hædersdal, Merete and Katoulis, Alexander and Läuchli, Severin and Lambert, Julien and Layton, Alison M and Micali, Giuseppe and Ochsendorf, Falk R and Sathyapalan, Thozhukat and Stangeland, Katarina Zak and Thomsen, Simon Francis and Töröcsik, Daniel and Pennitz, Antonia},
  title = {Update of the EuroGuiDerm evidence‐based guideline for the treatment of acne—Short version},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2026},
  doi = {10.1111/jdv.70331}
}
Kostenlos starten →